Skip to main content
Contact Us
Subscribe
E-Edition
43°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mei Pharma Inc
(NQ:
MEIP
)
2.800
-0.040 (-1.41%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mei Pharma Inc
Deal Dispatch: Starbucks Considers China Sale, Private Equity Bankrupts Snack Company, Darwin Financial Talks Mining
November 22, 2024
Darwin Financial's Joshua Robinson talks to Benzinga about the firm's latest commodities deal, and more M&A news from this past week.
Via
Benzinga
Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul
November 17, 2024
Evolent Health, Kronos Bio, Saint-Gobain, Shell and Unilever are on the sell-side this week. Benzinga's Deal Dispatch has the latest M&A updates.
Via
Benzinga
MEI Pharma Reports First Quarter Fiscal Year 2025 Cash Position
November 12, 2024
From
MEI Pharma, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
October 25, 2024
Via
Benzinga
MEI Pharma Reports Fiscal Year End 2024 Cash Position
September 19, 2024
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives
August 12, 2024
From
MEI Pharma, Inc.
Via
Business Wire
Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 22, 2024
Via
Benzinga
MEI Pharma to Consider Strategic Alternatives
July 22, 2024
From
MEI Pharma, Inc.
Via
Business Wire
7 Undervalued Biotech Stocks to Buy for Big-Time Returns
July 01, 2024
The broader healthcare sector enjoys a powerfully relevant narrative. Undervalued biotech stocks makes the case even more attractive.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
May 16, 2024
Via
Benzinga
Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)
May 14, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
MEIP Stock Earnings: MEI Pharma Beats EPS for Q3 2024
May 09, 2024
MEIP stock results show that MEI Pharma beat analyst estimates for earnings per share the third quarter of 2024.
Via
InvestorPlace
MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights
May 09, 2024
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients
April 11, 2024
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum
April 10, 2024
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia
March 26, 2024
From
MEI Pharma, Inc.
Via
Business Wire
5 Value Stocks In The Healthcare Sector
February 19, 2024
Via
Benzinga
Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)
February 15, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights
February 13, 2024
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma to Present Design of Ongoing Clinical Study Evaluating ME-344 at ASCO GI Cancers Symposium 2024
January 16, 2024
From
MEI Pharma, Inc.
Via
Business Wire
A Look Into Healthcare Sector Value Stocks
January 08, 2024
Via
Benzinga
Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)
December 14, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
MEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023
December 11, 2023
From
MEI Pharma, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
November 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 16, 2023
Via
Benzinga
MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights
November 09, 2023
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma to Present at the Stifel 2023 Healthcare Conference
November 08, 2023
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Declares Special Cash Dividend of $1.75 Per Share of Common Stock
November 06, 2023
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Announces Acceptance of Abstract for Presentation at ASH 2023
November 02, 2023
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Enters into Agreement with Anson Funds and Cable Car Capital
November 01, 2023
From
MEI Pharma, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
